PSEN2 (Presenilin-2) variants and mutations
PSEN2 (also known as Presenilin-2) is a human protein-coding gene encoding a presenilin-2 protein. Its gamma-secretase activity contributes to intramembrane cleavage of APP and other substrates in endolysosomal and cellular membranes. Pathogenic variants are a rare cause of autosomal dominant Alzheimer disease, generally with more variable penetrance and age of onset than PSEN1 variants. This analysis covers 765 PSEN2 variants and mutations. Of these, 69% have computational variant effect predictions. Disease context includes early-onset autosomal dominant Alzheimer disease, desmoid tumor, and dilated cardiomyopathy 1V. Example PSEN2 variants include M1R, L2F, and L2V.
Variant analysis overview
- Gene: PSEN2
- Protein: Presenilin-2
- UniProt accession: P49810
- Organism: Homo sapiens
- Variants analyzed: 765
- Variant scope: all variants
- Completed: 2026-08-10
Variant and mutation evidence
- Variant composition: 620 unspecified-consequence records; 63 synonymous variants; 57 missense variants; 12 frameshift variants; 2 stop-gained variants; 2 splice-region variants; 2 in-frame deletions; 7 substitution
- Prediction scores: 530 variants have prediction scores (69% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: early-onset autosomal dominant Alzheimer disease, desmoid tumor, dilated cardiomyopathy 1V, familial isolated dilated cardiomyopathy, Alzheimer disease, neoplasm, dementia, diabetes mellitus, fibromatosis, Parkinson disease, Huntington disease-like syndrome, complex regional pain syndrome.
Protein structure and variant hotspots
- Protein features: 8 transmembrane segments; 4 post-translational modification sites.
- Structural context: 231 variants have structural context.
- PTM context: 9 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PSEN2 variants
Examples include M1R, L2F, L2V, L2L, T3K, T3T, F4L, F4F. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1R (p.Met1Arg), rs762674312, ClinGen CA345329147, ClinVar RCV003391446, AlphaMissense 0.20, MetaLR 0.97, Uncertain significance, PSEN2-related disorder
- L2F (p.Leu2Phe), TOPMed rs199739625, gnomAD rs199739625, REVEL 0.41, CADD 22.60, Uncertain significance, Alzheimer disease 4
- L2V (p.Leu2Val), TOPMed rs199739625, gnomAD rs199739625, REVEL 0.43, CADD 21.20
- L2L (p.Leu2Leu), rs1203665828, gnomAD 1-226881913-C-G, CADD 6.77
- T3K (p.Thr3Lys), TOPMed rs1261261196, gnomAD rs1261261196, REVEL 0.60, CADD 22.60, Uncertain significance, Alzheimer disease 4
- T3T (p.Thr3Thr), gnomAD 1-226881916-A-G, CADD 3.24
- F4L (p.Phe4Leu), TOPMed rs1485007322, REVEL 0.61, CADD 22.70
- F4F (p.Phe4Phe), gnomAD 1-226881919-C-T, CADD 14.90
- M5T (p.Met5Thr), cosmic curated COSV10042, gnomAD rs1661019355, REVEL 0.60, CADD 22.90
- M5I (p.Met5Ile), gnomAD 1-226881922-G-C, REVEL 0.58, CADD 23.40
- A6S (p.Ala6Ser), cosmic curated COSV10042
- A6T (p.Ala6Thr), cosmic curated COSV10042
- A6A (p.Ala6Ala), rs763738488, gnomAD 1-226881925-C-T, CADD 12.80
- D8D (p.Asp8Asp), gnomAD 1-226881931-C-T, CADD 15.60
- S9G (p.Ser9Gly), rs786205285, ClinGen CA237497, ClinVar RCV000172096, Ensembl rs786205285, REVEL 0.56, CADD 24.40, Uncertain significance, not provided
- S9N (p.Ser9Asn), cosmic curated COSV60917, ExAC rs200878942, TOPMed rs200878942, gnomAD rs200878942, REVEL 0.49, CADD 26.10
- S9S (p.Ser9Ser), rs201692678, gnomAD 1-226881934-C-T, CADD 12.00
- E10G (p.Glu10Gly), TOPMed rs1661020551, REVEL 0.63, CADD 28.50
- E10K (p.Glu10Lys), cosmic curated COSV60915, TOPMed rs1454228189, gnomAD rs1454228189, REVEL 0.58, CADD 24.30
- E11G (p.Glu11Gly), TOPMed rs1275194154
- E11K (p.Glu11Lys), gnomAD 1-226881938-G-A, REVEL 0.52, CADD 27.80
- E12D (p.Glu12Asp), ExAC rs761147472, gnomAD rs761147472, REVEL 0.48, CADD 16.30
- E12V (p.Glu12Val), gnomAD 1-226881942-A-T, REVEL 0.61, CADD 26.40
- V13I (p.Val13Ile), cosmic curated COSV10042
- V13A (p.Val13Ala), rs766853710, ClinGen CA10609253, ClinVar RCV000262295, ClinVar RCV000317441, REVEL 0.42, CADD 18.20, Uncertain significance, Inborn genetic diseases; Alzheimer disease 4; Dilated cardiomyopathy 1V
- V13G (p.Val13Gly), ExAC rs766853710, gnomAD rs766853710, REVEL 0.46, CADD 21.80, Uncertain significance
- V13V (p.Val13Val), gnomAD 1-226881946-G-A, CADD 8.70
- C14F (p.Cys14Phe), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10042, Variant assessed as somatic; moderate impact.
- C14* (p.Cys14Ter), gnomAD 1-226881943-AGT-A, CADD 26.50
- C14Y (p.Cys14Tyr), gnomAD 1-226881948-G-A, REVEL 0.46, CADD 18.50
- C14C (p.Cys14Cys), gnomAD 1-226881949-T-C, CADD 9.05
- D15G (p.Asp15Gly), TOPMed rs1661021785
- D15H (p.Asp15His), cosmic curated COSV60915
- D15N (p.Asp15Asn), gnomAD 1-226881950-G-A, REVEL 0.40, CADD 18.40
- D15E (p.Asp15Glu), gnomAD 1-226881952-T-A, REVEL 0.47, CADD 8.78
- E16K (p.Glu16Lys), gnomAD 1-226881953-G-A, REVEL 0.69, CADD 29.50
- R17S (p.Arg17Ser), cosmic curated COSV10042
- R17L (p.Arg17Leu), TOPMed rs964890810, gnomAD rs964890810, REVEL 0.68, CADD 22.90, Uncertain significance
- R17Q (p.Arg17Gln), rs964890810, TOPMed rs964890810, gnomAD rs964890810, REVEL 0.60, CADD 22.90, Uncertain significance, not provided
- R17W (p.Arg17Trp), rs199644116, ClinGen CA237499, ClinVar RCV000172097, ExAC rs199644116, REVEL 0.72, CADD 25.70, Uncertain significance, not provided
- R17G (p.Arg17Gly), gnomAD 1-226881956-C-G, REVEL 0.64, CADD 23.30
- T18M (p.Thr18Met), rs143061887, ClinGen CA1424373, cosmic curated COSV10522, ClinVar RCV001263187, REVEL 0.56, CADD 24.70, Uncertain significance, not provided; Alzheimer disease 4; not specified
- T18T (p.Thr18Thr), rs201018913, gnomAD 1-226881961-G-A, CADD 0.23
- L20L (p.Leu20Leu), gnomAD 1-226881967-A-G, CADD 6.03
- M21I (p.Met21Ile), ExAC rs752960820, gnomAD rs752960820, REVEL 0.47, CADD 18.00
- M21L (p.Met21Leu), cosmic curated COSV10042
- M21R (p.Met21Arg), gnomAD 1-226881969-T-G, REVEL 0.60, CADD 20.80
- S22L (p.Ser22Leu), cosmic curated COSV10590, 1000Genomes rs552406611, ExAC rs552406611, TOPMed rs552406611, REVEL 0.42, CADD 19.00, Uncertain significance, Alzheimer disease 4
- S22* (p.Ser22Ter), gnomAD 1-226881972-C-A, CADD 36.00
- S22S (p.Ser22Ser), rs367645069, gnomAD 1-226881973-G-A, CADD 0.10
- A23S (p.Ala23Ser), cosmic curated COSV60917
- A23T (p.Ala23Thr), cosmic curated COSV60916
- A23V (p.Ala23Val), gnomAD 1-226881975-C-T, REVEL 0.51, CADD 17.10
- A23A (p.Ala23Ala), rs11405, gnomAD 1-226881976-T-C, CADD 1.27
- E24K (p.Glu24Lys), ExAC rs757152552, TOPMed rs757152552, gnomAD rs757152552, REVEL 0.61, CADD 23.10
- S25N (p.Ser25Asn), gnomAD rs1661025159, REVEL 0.50, CADD 16.70
- S25C (p.Ser25Cys), gnomAD 1-226881980-A-T, REVEL 0.55, CADD 21.00
- S25G (p.Ser25Gly), gnomAD 1-226881980-A-G, REVEL 0.58, CADD 18.90
- P26L (p.Pro26Leu), ExAC rs781116134, TOPMed rs781116134, gnomAD rs781116134, REVEL 0.62, CADD 20.60
- T27A (p.Thr27Ala), ESP rs147326133, ExAC rs147326133, TOPMed rs147326133, gnomAD rs147326133, REVEL 0.27, CADD 0.75
- T27K (p.Thr27Lys), ESP rs149354305, ExAC rs149354305, TOPMed rs149354305, gnomAD rs149354305, REVEL 0.37, CADD 3.26, Uncertain significance
- T27M (p.Thr27Met), rs149354305, ClinGen CA1424382, cosmic curated COSV60918, ClinVar RCV001060794, REVEL 0.32, CADD 8.49, Uncertain significance, Alzheimer disease 4; Inborn genetic diseases
- T27T (p.Thr27Thr), rs144696679, gnomAD 1-226881988-G-A, CADD 0.08
- P28L (p.Pro28Leu), ExAC rs748504448, TOPMed rs748504448, gnomAD rs748504448, REVEL 0.34, CADD 11.80, Uncertain significance, Alzheimer disease 4
- P28R (p.Pro28Arg), ExAC rs748504448, TOPMed rs748504448, gnomAD rs748504448
- P28S (p.Pro28Ser), cosmic curated COSV60917, ExAC rs749015914, TOPMed rs749015914
- P28T (p.Pro28Thr), ExAC rs749015914, TOPMed rs749015914, REVEL 0.34, CADD 3.09, Uncertain significance, Alzheimer disease 4
- P28P (p.Pro28Pro), rs371475270, gnomAD 1-226881991-G-A, CADD 0.17
- R29C (p.Arg29Cys), rs142892469, ClinGen CA1424387, ClinVar RCV001985484, ClinVar RCV002484755, REVEL 0.40, CADD 22.90, Uncertain significance, not specified; not provided; Alzheimer disease 4
- R29H (p.Arg29His), rs771375988, NCI-TCGA Cosmic COSV6091, cosmic curated COSV60914, ExAC rs771375988, REVEL 0.37, CADD 21.50, Variant assessed as somatic; moderate impact.
- R29L (p.Arg29Leu), ExAC rs771375988, TOPMed rs771375988, gnomAD rs771375988, REVEL 0.36, CADD 15.50
- R29R (p.Arg29Arg), rs1661027962, gnomAD 1-226881994-C-T, CADD 4.82
- S30F (p.Ser30Phe), cosmic curated COSV10042
- S30S (p.Ser30Ser), gnomAD 1-226881997-C-T, CADD 10.30
- C31F (p.Cys31Phe), cosmic curated COSV10042
- C31S (p.Cys31Ser), gnomAD 1-226881999-G-C, REVEL 0.44, CADD 13.90
- C31C (p.Cys31Cys), rs2102668171, gnomAD 1-226882000-C-T, CADD 12.40
- Q32E (p.Gln32Glu), ExAC rs760011841, TOPMed rs760011841, gnomAD rs760011841, REVEL 0.41, CADD 14.60
- Q32R (p.Gln32Arg), gnomAD rs1458154730, REVEL 0.43, CADD 17.20
- Q32Q (p.Gln32Gln), gnomAD 1-226882003-G-A, CADD 7.78
- E33G (p.Glu33Gly), NCI-TCGA Cosmic COSV6091, cosmic curated COSV60915, Variant assessed as somatic; moderate impact.
- E33K (p.Glu33Lys), gnomAD rs1294909986, REVEL 0.41, CADD 21.70
- G34D (p.Gly34Asp), cosmic curated COSV10042
- G34A (p.Gly34Ala), TOPMed rs1439853463, gnomAD rs1439853463, REVEL 0.35, CADD 10.50
- G34S (p.Gly34Ser), rs200636353, ClinGen CA1424391, ClinVar RCV000894684, ClinVar RCV001101118, REVEL 0.33, CADD 17.70, Conflicting interpretations, Alzheimer disease 4; Dilated cardiomyopathy 1V
- G34G (p.Gly34Gly), gnomAD 1-226882009-C-T, CADD 14.10
- R35K (p.Arg35Lys), gnomAD rs1331745449
- R35S (p.Arg35Ser), rs1379056144, ClinGen CA345329364, ClinVar RCV003404296, gnomAD rs1379056144, REVEL 0.39, CADD 12.30, Uncertain significance, PSEN2-related disorder
- R35R (p.Arg35Arg), rs1335789538, gnomAD 1-226882010-A-C, CADD 5.70
- Q36R (p.Gln36Arg), gnomAD rs1389549012, REVEL 0.23, CADD 1.02
- Q36Q (p.Gln36Gln), rs1036852050, gnomAD 1-226882015-G-A, CADD 0.98
- G37D (p.Gly37Asp), cosmic curated COSV60917, TOPMed rs1231154581, gnomAD rs1231154581, REVEL 0.33, CADD 7.98
- G37R (p.Gly37Arg), Ensembl rs1558143495, REVEL 0.35, CADD 15.00
- G37A (p.Gly37Ala), gnomAD 1-226882017-G-C, REVEL 0.32, CADD 3.85
- G37G (p.Gly37Gly), rs139309459, gnomAD 1-226882018-C-T, CADD 3.71
- E39E (p.Glu39Glu), gnomAD 1-226882024-G-A, CADD 4.01
- D40V (p.Asp40Val), gnomAD rs1306395711, REVEL 0.41, CADD 17.90
- D40G (p.Asp40Gly), gnomAD 1-226882026-A-G, REVEL 0.46, CADD 19.70
- G41G (p.Gly41Gly), rs1322405373, gnomAD 1-226882030-A-C, CADD 5.70
- E42D (p.Glu42Asp), gnomAD rs1247314279
- E42K (p.Glu42Lys), gnomAD 1-226882031-G-A, REVEL 0.35, CADD 19.10
- N43K (p.Asn43Lys), 1000Genomes rs6759, ESP rs6759, ExAC rs6759, TOPMed rs6759, Benign
- N43N (p.Asn43Asn), rs6759, gnomAD 1-226882036-C-T, CADD 4.93
- T44A (p.Thr44Ala), Ensembl rs200535276, REVEL 0.27, CADD 5.67
- T44P (p.Thr44Pro), Ensembl rs200535276
- T44T (p.Thr44Thr), rs143227762, gnomAD 1-226882039-T-A, CADD 0.75
- A45V (p.Ala45Val), ExAC rs751593722, TOPMed rs751593722, gnomAD rs751593722, REVEL 0.44, CADD 17.60
- A45T (p.Ala45Thr), gnomAD 1-226882040-G-A, REVEL 0.28, CADD 9.36
- Q46* (p.Gln46Ter), ExAC rs757319285, TOPMed rs757319285, gnomAD rs757319285, CADD 40.00
- Q46S (p.Gln46Ser), gnomAD 1-226882040-GC-G, CADD 24.10
- Q46R (p.Gln46Arg), gnomAD 1-226882044-A-G, REVEL 0.47, CADD 21.80
- Q46Q (p.Gln46Gln), rs1661034551, gnomAD 1-226882045-G-A, CADD 8.25
- W47* (p.Trp47Ter), rs1412682521, ClinGen CA345329443, ClinVar RCV002248138, TOPMed rs1412682521, CADD 44.00, Uncertain significance
- W47G (p.Trp47Gly), rs2102668369, ClinGen CA345329442, ClinVar RCV001894357, Ensembl rs2102668369, AlphaMissense 0.08, MetaLR 0.89, Uncertain significance, Alzheimer disease 4
- W47S (p.Trp47Ser), TOPMed rs1412682521, gnomAD rs1412682521, REVEL 0.46, CADD 22.10, Uncertain significance
- W47C (p.Trp47Cys), cosmic curated COSV10522
- R48K (p.Arg48Lys), Ensembl rs2102672058, REVEL 0.35, CADD 22.40
- R48R (p.Arg48Arg), gnomAD 1-226883707-A-G, CADD 16.10
- S49G (p.Ser49Gly), Ensembl rs1661146172
- S49N (p.Ser49Asn), TOPMed rs1051303953, gnomAD rs1051303953, REVEL 0.31, CADD 14.40
- S49A (p.Ser49Ala), rs1420282492, gnomAD 1-226883706-GA-G, CADD 25.60
- S49R (p.Ser49Arg), gnomAD 1-226883710-C-G, REVEL 0.46, CADD 17.50
- Q50R (p.Gln50Arg), rs143501870, ClinGen CA346593, ClinVar RCV000157425, ClinVar RCV001097368, REVEL 0.41, CADD 18.90, Conflicting interpretations, Alzheimer disease 4; Dilated cardiomyopathy 1V; not specified
- Q50K (p.Gln50Lys), cosmic curated COSV10042
- Q50E (p.Gln50Glu), gnomAD 1-226883711-C-G, REVEL 0.45, CADD 15.20
- Q50Q (p.Gln50Gln), gnomAD 1-226883713-G-A, CADD 8.25
- E51D (p.Glu51Asp), Ensembl rs1558144887, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E51E (p.Glu51Glu), gnomAD 1-226883716-G-A, CADD 0.31
- N52D (p.Asn52Asp), ExAC rs775935657, gnomAD rs775935657, REVEL 0.29, CADD 5.25
- N52K (p.Asn52Lys), NCI-TCGA Cosmic COSV1004, cosmic curated COSV10042, Variant assessed as somatic; moderate impact.
- N52S (p.Asn52Ser), Ensembl rs1661147574
- N52N (p.Asn52Asn), rs749675208, gnomAD 1-226883719-C-T, CADD 2.91
- E53K (p.Glu53Lys), TOPMed rs1216954105, gnomAD rs1216954105, REVEL 0.59, CADD 19.80
- E54D (p.Glu54Asp), rs146894466, ClinGen CA1424429, ClinVar RCV001488849, ClinVar RCV002507535, REVEL 0.40, CADD 12.80, Benign/Likely benign, Alzheimer disease 4; Dilated cardiomyopathy 1V; not specified
- E54Q (p.Glu54Gln), gnomAD 1-226883723-G-C, REVEL 0.36, CADD 22.20
- E54E (p.Glu54Glu), rs146894466, gnomAD 1-226883725-G-A, CADD 5.89
- D55E (p.Asp55Glu), rs139332886, ClinGen CA345329517, ClinVar RCV003620352, ESP rs139332886, REVEL 0.43, CADD 1.44, Uncertain significance, Alzheimer disease 4
- D55D (p.Asp55Asp), rs139332886, gnomAD 1-226883728-C-T, CADD 3.28
- G56S (p.Gly56Ser), rs188598190, ClinGen CA237501, cosmic curated COSV10042, ClinVar RCV000172098, REVEL 0.37, CADD 8.24, Conflicting interpretations, not specified; not provided; Alzheimer disease 4
- p.Gly56 Asp59del, rs779700692, gnomAD 1-226883719-CGAGG, CADD 20.50
- G56A (p.Gly56Ala), gnomAD 1-226883730-G-C, REVEL 0.37, CADD 6.84
- E57K (p.Glu57Lys), gnomAD 1-226883732-G-A, REVEL 0.44, CADD 22.30
- E58* (p.Glu58Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E58K (p.Glu58Lys), TOPMed rs1661149148
- D59E (p.Asp59Glu), ExAC rs767577993, TOPMed rs767577993, gnomAD rs767577993, REVEL 0.34, CADD 10.70, Likely benign
- D59D (p.Asp59Asp), rs767577993, gnomAD 1-226883740-C-T, CADD 7.63
- P60S (p.Pro60Ser), Ensembl rs2102672203, REVEL 0.46, CADD 9.31
- P60L (p.Pro60Leu), gnomAD 1-226883739-AC-A, CADD 23.00
- P60P (p.Pro60Pro), rs1661149633, gnomAD 1-226883743-T-C, CADD 3.45
- D61D (p.Asp61Asp), rs201261403, gnomAD 1-226883746-C-T, CADD 6.18
- R62C (p.Arg62Cys), rs150400387, ClinGen CA1424432, ClinVar RCV000687794, ClinVar RCV001584558, REVEL 0.40, CADD 23.40, Uncertain significance, not specified; not provided; Alzheimer disease 4
- R62G (p.Arg62Gly), ESP rs150400387, ExAC rs150400387, TOPMed rs150400387, gnomAD rs150400387, REVEL 0.42, CADD 16.10, Uncertain significance, in AD4
- R62H (p.Arg62His), rs58973334, ClinGen CA224946, ClinVar RCV000084258, ClinVar RCV000172777, REVEL 0.29, CADD 6.29, Benign/Likely benign, not specified; not provided; Alzheimer disease
- R62P (p.Arg62Pro), 1000Genomes rs58973334, ESP rs58973334, ExAC rs58973334, TOPMed rs58973334, Benign, in AD4
- R62S (p.Arg62Ser), cosmic curated COSV60916, ESP rs150400387, ExAC rs150400387, TOPMed rs150400387, REVEL 0.45, CADD 14.90, Uncertain significance, in AD4
- Y63C (p.Tyr63Cys), gnomAD rs1661151005, REVEL 0.43, CADD 19.10, Uncertain significance, not specified
- Y63S (p.Tyr63Ser), gnomAD 1-226883751-A-C, REVEL 0.61, CADD 16.10
- V64I (p.Val64Ile), gnomAD rs1420351247, REVEL 0.24, CADD 0.92
- V64V (p.Val64Val), rs201272715, gnomAD 1-226883755-C-T, CADD 2.35
- C65Y (p.Cys65Tyr), rs766446160, ClinGen CA1424433, ClinVar RCV003510438, ClinVar RCV005419641, REVEL 0.43, CADD 17.30, Uncertain significance, not specified; Alzheimer disease 4
- S66C (p.Ser66Cys), ExAC rs753871802, TOPMed rs753871802, REVEL 0.39, CADD 19.60
- S66N (p.Ser66Asn), ExAC rs754836755, gnomAD rs754836755, REVEL 0.38, CADD 18.20
- G67D (p.Gly67Asp), cosmic curated COSV60914
- G67W (p.Gly67Trp), gnomAD 1-226883762-G-T, REVEL 0.59, CADD 24.50
- G67E (p.Gly67Glu), gnomAD 1-226883763-G-A, REVEL 0.55, CADD 17.80
- G67G (p.Gly67Gly), rs1661152624, gnomAD 1-226883764-G-C, CADD 2.05
- V68A (p.Val68Ala), rs765144719, ClinGen CA1424436, ClinVar RCV001363163, ClinVar RCV002476655, REVEL 0.33, CADD 6.74, Uncertain significance, Alzheimer disease 4; Dilated cardiomyopathy 1V
- V68G (p.Val68Gly), ExAC rs765144719, TOPMed rs765144719, gnomAD rs765144719, REVEL 0.32, CADD 10.10, Uncertain significance
- p.Val68 Gly70del, rs1400526624, gnomAD 1-226883761-TGGGG, CADD 15.90
- V68L (p.Val68Leu), gnomAD 1-226883765-G-C, REVEL 0.43, CADD 14.10
- P69A (p.Pro69Ala), rs202133351, ClinGen CA237503, ClinVar RCV000172099, ClinVar RCV000763832, REVEL 0.43, CADD 11.20, Conflicting interpretations, not specified; not provided; Alzheimer disease 4
- P69R (p.Pro69Arg), ExAC rs199968912, gnomAD rs199968912, REVEL 0.42, CADD 12.90
- P69S (p.Pro69Ser), cosmic curated COSV60917, ESP rs202133351, ExAC rs202133351, TOPMed rs202133351, REVEL 0.43, CADD 10.80, Uncertain significance
- P69T (p.Pro69Thr), ESP rs202133351, ExAC rs202133351, TOPMed rs202133351, gnomAD rs202133351, REVEL 0.54, CADD 12.60, Uncertain significance
- P69L (p.Pro69Leu), gnomAD 1-226883769-C-T, REVEL 0.45, CADD 14.30
- P69P (p.Pro69Pro), rs142546082, gnomAD 1-226883770-C-T, CADD 0.09
- G70R (p.Gly70Arg), rs139972151, ClinGen CA238430, cosmic curated COSV60919, ClinVar RCV000172586, REVEL 0.46, CADD 19.20, Conflicting interpretations, not provided; Alzheimer disease 4
- R71L (p.Arg71Leu), ExAC rs769031756, TOPMed rs769031756, gnomAD rs769031756, REVEL 0.49, CADD 22.50, Uncertain significance, in AD4
- R71Q (p.Arg71Gln), ExAC rs769031756, TOPMed rs769031756, gnomAD rs769031756, REVEL 0.47, CADD 19.10, Uncertain significance, in AD4
- R71W (p.Arg71Trp), rs140501902, ClinGen CA199983, cosmic curated COSV10522, ClinVar RCV000172587, REVEL 0.61, CADD 22.40, Benign/Likely benign, not specified; not provided; Alzheimer disease 4
Public PSEN2 analysis runs
- PSEN2 analysis run — PSEN2 (765 variants) — completed 2026-08-10